Jobs at Navanti

Department: Program
Employment Type: Independent Contractor / Short-Term Technical Assistance (STTA)
Team: USAID/Nigeria MEL Support Activity
Reporting to: Assessment and Evaluation Advisor
Period of Performance: November 2024 – May 2025
Project: USAID/Nigeria Health Population and Nutrition (HPN) Office

Backgroud

• Navanti supports a Monitoring, Evaluation, and Learning (MEL) Support Activity program that assists USAID/Nigeria in advancing its broader organizational learning and development efforts.
• This program strengthens the Mission’s capacity and performance in programmatic monitoring, evaluation, learning, collaborating, and adapting.
• The MEL Support Activity closely aligns with USAID/Nigeria’s Country Development Cooperation Strategy (CDCS).
• It provides a broad range of specialized technical assistance, training, data gathering and analysis, field-based monitoring, evaluations and assessments, facilitation of organizational learning and adaptation initiatives, and short-term technical assistance.

Overview and Evaluation Purpose

• USAID/Nigeria has engaged the MEL Support Activity to evaluate the Drug Revolving Fund (DRF) Activity to determine whether it meets its stated objectives.
• The evaluation will ascertain if the assistance provided by USAID/Nigeria through the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project on DRF Activity achieved the stated development objectives (DO).
• The evaluation also seeks to understand the lessons from this Activity in Nigeria.
• The purpose is to evaluate the effectiveness, promote accountability, inform decision-making, ensure the program's sustainability and impact on improving access to essential medicines and healthcare services, and inform USAID/Nigeria’s potential future support for drug revolving funds.
• The study will provide specific insights into the following proposed states:
  • North-West: Zamfara, Sokoto
  • North-East: Bauchi
  • North-Central: Nasarawa

About Drug Revolving Fund (DRF)

• The drug revolving fund (DRF) is a financing mechanism used in healthcare to improve access to essential drugs and medicines.
• The primary goal of a DRF is to ensure a steady supply of quality medications and to prevent stockouts or shortages in public health facilities, such as hospitals and health centers.

The purpose of the DRF is as follows:

• Ensure the availability and sustainability of quality health commodities.
• Ensure accessibility and affordability of health commodities.
• Contribute to the attainment of universal health coverage.
• Support health care for the vulnerable.

USAID expected the DRF support to achieve the following high-level results:

• Improved access to essential medicines particularly in underserved areas at an affordable rate
• Strengthened health systems through improved capacity, governance, and coordination of supply chain management, procurement processes, and monitoring systems.
• Curtail dependence on external funding.
• Streamline the procurement and distribution of medicines, leading to more efficient health service delivery. This can result in shorter waiting times, improved patient satisfaction, and improved overall quality of care in health facilities.
• Improve revenue generation and sustainability through revolving/recycling funds from the sale of medicines and pharmaceutical products.
• The primary users of the evaluation findings will be the USAID Health Population and Nutrition (HPN) Office, other U.S. Government (USG) officials, non-USG donor organizations, GON, and private sector firms, all of whom can use the findings to improve and build knowledge.
• The result of this evaluation will be used by the Mission, GON, implementing partners, and other stakeholders to enhance accountability and learning and to inform decisions on further investment and whether or not the DRF is being re-capitalized.
• The estimated start date will be November 11, 2024. The evaluation is expected to last until May 2025.

Position Description

• Navanti is seeking a team leader responsible for the overall coordination and management of the evaluation team’s effort and for ensuring a rigorous and high-quality evaluation in the locations stated above.
• Under the guidance of the MEL Support Activity, the team leader is expected to work closely with the USAID/Nigeria-HPN team. The team lead is expected to have done a similar evaluation in sub-Saharan Africa, or other countries with similar context.
• The team leader will be supported by a subject matter expert, a health financing specialist, a procurement and logistics expert, and a health data/evaluation specialist.
• The team leader will consult with and facilitate input from all team members throughout the evaluation.
• The team will use a combination of literature review, secondary analysis of population-based surveys, and quantitative/qualitative data collection through focus group discussions and in-depth interviews to gather insights to answer the study questions, with a special focus on data from the four states listed above.
• The team is also expected to propose based evaluation methodology/approach as required.

Responsibilities

• The evaluation team leader will be responsible for the overall management of the evaluation. S/he will be the primary person responsible for ensuring a rigorous and high-quality evaluation design.
• The team leader will develop the outline for the draft report, present the report, and after incorporating USAID/Nigeria staff comments, submit the final report to USAID/Nigeria through the MEL Support Activity within the prescribed timeline.

The team leader will:

• Participate in the evaluation kick-off session with USAID/Nigeria.
• Conduct an initial desk study: gather relevant secondary materials to identify key actors and stakeholders.
• Lead the development of data collection tools, including survey and interview tools, and methodology for covering target states
• Conduct and manage the entire process of data collection, including conducting several KIIs and FGDs with stakeholders including women, health care providers, etc
• Present preliminary findings on data collected from stakeholders' engagement and desk review
• Provide leadership for the team and coordinate activities as necessary.
• Coordinate team's ongoing analysis of qualitative and quantitative data.
• Lead the preparation and presentation of the In-brief and Out-brief to USAID/Nigeria and other stakeholders as requested.
• Write the draft evaluation report with support from the team members, taking into consideration feedback from the Out-brief presentation.
• Respond to USAID comments on the draft report, incorporate USAID/Nigeria staff comments into the final version of the report, and finalize the report.
• Present the rapid evaluation results to diverse audiences according to USAID standard reporting
• Work collaboratively with team members throughout design, implementation, analysis, and report writing to complement each other's areas of expertise.

Qualifications

The candidate is expected to have the following qualifications:

• Candidates should possess a minimum of a Master's Degree in a relevant field: Pharmaceutical Studies, Supply Chain Management, Economics, Health Planning, or Public/Global Health.
• Minimum of seven or more years of substantive and progressively responsible professional experience working in pharmaceutical supply chain, commodities, logistics management, and health systems in Nigeria.
• Specific experience in supply chain and logistics related to malaria and MNCH preferred.
• Experience evaluating/supporting start-up/improvement management/implementation of drug revolving funds is critical. Proficiency in evaluation methods, and quantitative and qualitative research methods including survey design, data collection, statistical analysis, and interpretation of findings. This will be complemented by strong written and verbal communication skills and the ability to prepare clear and concise evaluation reports, presentations, and briefs tailored to different audiences.
• Supply chain experience working with the Government of Nigeria at the national, state, and/or facility level or similar context is an advantage.
• Experience in measurement methods required for monitoring and evaluation of programs.
• Demonstrated experience with supply chain capacity building and policy reform, with preference to those with considerable working experience in Nigeria.
• Experience in preparing persuasive technical reports and making verbal presentations,
• explaining issues clearly and concisely.
• Required oral and written communication and presentation skills in English.
• Demonstrated experience in collaborating across projects stakeholder groups and donor projects.
• A minimum of seven years or more substantive and progressively responsible professional experience designing and conducting evaluations is required.
• Proficiency in evaluation methods, and quantitative and qualitative research methods including survey design, data collection, statistical analysis, and interpretation of findings. This includes experimental/quasi-experimental designs, and case studies, to assess program effectiveness, efficiency, relevance, sustainability, and impact. This will be complemented by strong written and verbal communication skills and the ability to prepare clear and concise evaluation reports, presentations, and briefs tailored to different audiences.
• A solid understanding of public health principles, policies, and practices especially related to pharmaceuticals, healthcare financing, and access to medicines.
• Familiarity with health system dynamics, including financing mechanisms, procurement, supply chain management, service delivery structures, and regulatory frameworks related to pharmaceutical and drug revolving fund schemes
• Sensitivity to cultural nuances, local customs, and social dynamics in Nigeria to ensure effective engagement with stakeholders and accurate interpretation of findings within the local context.
• Experience working in the health sector with international donor organizations, particularly USAID
• The consultant should adhere to ethical guidelines, obtain informed consent, and protect the confidentiality and anonymity of participants.

go to method of application »

Employment Type: Independent Contractor / Short-Term Technical Assistance (STTA)
Team: USAID / Nigeria MEL Support Activity
Reporting to: Assessment and Evaluation Advisor
Period of Performance: November 2024 – May 2025
Project: USAID/Nigeria Health Population and Nutrition (HPN) Office

Background

• Navanti supports a Monitoring, Evaluation, and Learning (MEL) Support Activity program that assists USAID/Nigeria in advancing its broader organizational learning and development efforts.
• This program strengthens the Mission’s capacity and performance in programmatic monitoring, evaluation, learning, collaborating, and adapting.
• The MEL Support Activity closely aligns with USAID/Nigeria’s Country Development Cooperation Strategy (CDCS).
• It provides a broad range of specialized technical assistance, training, data gathering and analysis, field-based monitoring, evaluations and assessments, facilitation of organizational learning and adaptation initiatives, and short-term technical assistance.

Overview and Evaluation Purpose

• USAID/Nigeria has engaged the MEL Support Activity to evaluate the Drug Revolving Fund (DRF) Activity to determine whether it meets its stated objectives.
• The evaluation will ascertain if the assistance provided by USAID/Nigeria through the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project on DRF Activity achieved the stated development objectives (DO).
• The evaluation also seeks to understand the lessons from this Activity in Nigeria.
• The purpose is to evaluate the effectiveness, promote accountability, inform decision-making, ensure the program's sustainability and impact on improving access to essential medicines and healthcare services, and inform USAID/Nigeria’s potential future support for drug revolving funds.
• The study will provide specific insights into the following proposed states:
  • North-West: Zamfara, Sokoto
  • North-East: Bauchi
  • North-Central: Nasarawa

About Drug Revolving Fund (DRF)

• The drug revolving fund (DRF) is a financing mechanism used in healthcare to improve access to essential drugs and medicines.
• The primary goal of a DRF is to ensure a steady supply of quality medications and to prevent stockouts or shortages in public health facilities, such as hospitals and health centers.

The purpose of the DRF is as follows:

• Ensure the availability and sustainability of quality health commodities.
• Ensure accessibility and affordability of health commodities.
• Contribute to the attainment of universal health coverage.
• Support health care for the vulnerable.

USAID expected the DRF support to achieve the following high-level results:

• Improved access to essential medicines particularly in underserved areas at an affordable rate
• Strengthened health systems through improved capacity, governance, and coordination of supply chain management, procurement processes, and monitoring systems.
• Curtail dependence on external funding.
• Streamline the procurement and distribution of medicines, leading to more efficient health service delivery. This can result in shorter waiting times, improved patient satisfaction, and improved overall quality of care in health facilities.
• Improve revenue generation and sustainability through revolving/recycling funds from the sale of medicines and pharmaceutical products.
• The primary users of the evaluation findings will be the USAID Health Population and Nutrition (HPN) Office, other U.S. Government (USG) officials, non-USG donor organizations, GON, and private sector firms, all of whom can use the findings to improve and build knowledge.
• The result of this evaluation will be used by the Mission, GON, implementing partners, and other stakeholders to enhance accountability and learning and to inform decisions on further investment and whether or not the DRF is being re-capitalized.
• The estimated start date will be November 11, 2024. The evaluation is expected to last until May 2025.

Position Description

• Navanti is seeking a research/data analyst responsible for supporting the team lead in developing context-specific tools for engaging various stakeholders for this evaluation.
• S/he will be responsible for analyzing the quantitative and qualitative data and conducting multi-level bivariate and multivariate analyses of the data.
• The Research/Data Analyst will work with the team leader to conduct interviews, analyze the data, and develop the evaluation report
• Under the guidance of the MEL Support Activity, the research/data analyst is expected to work closely with the USAID/Nigeria-HPN team.
• The team will use a combination of literature review, secondary analysis of population-based surveys, and quantitative/qualitative data collection through focus group discussions and in-depth interviews to gather insights to answer the study questions, with a special focus on data from the four states listed above.
• The team is also expected to propose based evaluation methodology/approach as required.

Responsibilities

• The health data/evaluation specialist will be responsible for developing comprehensive data collection tools, analyzing data, and providing insights into data collected by the evaluation team.

The health data/evaluation specialist will:

• Participate in the evaluation kick-off session with USAID/Nigeria.
• Develop quantitative tools resulting from desk review
• Provides substantive technical input into the development of data collection tools, including survey and interview tools, and methodology for covering target states
• Support the data collection process, including conducting several KIIs and FGDs with stakeholders including women, health care providers, etc
• Analyse data and present findings.
• Support in the presentation of preliminary findings on data collected from stakeholders' engagement and desk review
• Coordinates closely with other evaluation teams to ensure quality evaluation
• Support the team lead in writing the draft evaluation report with support from the team members, taking into consideration feedback from the Out-brief presentation.
• Respond to USAID comments on the draft report, incorporate USAID/Nigeria staff comments into the final version of the report, and finalize the report.
• Work collaboratively with team members throughout design, implementation, analysis, and report writing to complement each other's areas of expertise.

Qualifications

The candidate is expected to have the following qualifications:

• Education: A Bachelor's Degree in Statistics, Mathematics, Computer Science, Economics, Business Administration, or a related field is preferable. A master's degree or certification in data analysis, supply chain management, public health, or biostatistics will be advantageous.
• Working experience: Minimum of five years of progressive working experience in data analysis and research in the public health/healthcare domain.
• Analytical Skills: Proficiency in statistical methods and data analysis tools for both quantitative and qualitative data (e.g., SPSS, SAS, R, Python, NVivo, Dedoose, ATLAS.ti) to interpret complex data sets and identify trends within the supply chain drug revolving fund system.
• Supply Chain Management Knowledge: Understanding of supply chain principles and inventory management practices within the pharmaceutical space to effectively evaluate the performance of the drug revolving fund.
• Research Experience: Ability to design, conduct, and analyze research/studies related to healthcare logistics and pharmaceutical supply chains with a focus on cost-effectiveness, inventory control methods, demand forecasting, etc.
• Data Visualization: Proficiency in using visualization tools (e.g., Excel, Tableau, Power BI) to present findings through graphs and charts for easy comprehension by stakeholders.
• Communication Skills: Strong written and verbal communication skills are essential for conveying research findings effectively to diverse audiences including policymakers and healthcare professionals.
• Problem-Solving Abilities: Capacity to identify inefficiencies within the drug revolving fund system through data analysis and propose improvement solutions.
• Attention to Detail: Thoroughness in analyzing datasets containing complex information related to procurement patterns, stock levels, distribution networks as well as financial aspects such as repayment rates or interest charges on loans from the fund.
• Teamwork Collaboration Skills: Capability of working collaboratively with multidisciplinary teams including pharmacists, finance managers, and public health specialists alongside other stakeholders involved in managing the drug revolving fund evaluation.

go to method of application »

Overview and Evaluation Purpose

• USAID/Nigeria has engaged the MEL Support Activity to evaluate the Drug Revolving Fund (DRF) Activity to determine whether it meets its stated objectives.
• The evaluation will ascertain if the assistance provided by USAID/Nigeria through the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project on DRF Activity achieved the stated development objectives (DO).
• The evaluation also seeks to understand the lessons from this Activity in Nigeria.
• The purpose is to evaluate the effectiveness, promote accountability, inform decision-making, ensure the program's sustainability and impact on improving access to essential medicines and healthcare services, and inform USAID/Nigeria’s potential future support for drug revolving funds.
• The study will provide specific insights into the following proposed states:
  • North-West: Zamfara, Sokoto
  • North-East: Bauchi
  • North-Central: Nasarawa

About Drug Revolving Fund (DRF)

• The drug revolving fund (DRF) is a financing mechanism used in healthcare to improve access to essential drugs and medicines.
• The primary goal of a DRF is to ensure a steady supply of quality medications and to prevent stockouts or shortages in public health facilities, such as hospitals and health centers.

The purpose of the DRF is as follows:

• Ensure the availability and sustainability of quality health commodities.
• Ensure accessibility and affordability of health commodities.
• Contribute to the attainment of universal health coverage.
• Support health care for the vulnerable.

USAID expected the DRF support to achieve the following high-level results:

• Improved access to essential medicines particularly in underserved areas at an affordable rate
• Strengthened health systems through improved capacity, governance, and coordination of supply chain management, procurement processes, and monitoring systems.
• Curtail dependence on external funding.
• Streamline the procurement and distribution of medicines, leading to more efficient health service delivery. This can result in shorter waiting times, improved patient satisfaction, and improved overall quality of care in health facilities.
• Improve revenue generation and sustainability through revolving/recycling funds from the sale of medicines and pharmaceutical products.
• The primary users of the evaluation findings will be the USAID Health Population and Nutrition (HPN) Office, other U.S. Government (USG) officials, non-USG donor organizations, GON, and private sector firms, all of whom can use the findings to improve and build knowledge.
• The result of this evaluation will be used by the Mission, GON, implementing partners, and other stakeholders to enhance accountability and learning and to inform decisions on further investment and whether or not the DRF is being re-capitalized.
• The estimated start date will be November 11, 2024. The evaluation is expected to last until May 2025.

Position Description

• Navanti is seeking a DRF Finance Specialist to support the team lead in developing context-specific tools for engaging various stakeholders, providing context to the evaluation, and supporting the development of the report.
• The subject matter expert will work with the team leader to conduct interviews, analyze the data, and develop the evaluation report responsible for the overall coordination and management of the evaluation team’s effort and for ensuring a rigorous and high-quality evaluation in the locations stated above.
• Under the guidance of the MEL Support Activity, the subject matter expert is expected to work closely with the USAID/Nigeria-HPN team.
• The team will use a combination of literature review, secondary analysis of population-based surveys, and quantitative/qualitative data collection through focus group discussions and in-depth interviews to gather insights to answer the study questions, with a special focus on data from the four states listed above.
• The team is also expected to propose based evaluation methodology/approach as required.

Responsibilities

• The DRF Finance Specialist will be responsible for providing direct technical assistance to the team leader on key strategies to engage targeted stakeholders in conducting the evaluation.

The subject matter expert will:

• Participate in the evaluation kick-off session with USAID/Nigeria.
• Support in conducting an initial desk study: gather relevant secondary materials to identify key actors and stakeholders. A summary of these findings will help to better understand the context, identify key stakeholders to be interviewed, and guide the finalization of the design for the evaluation including the questions to be explored further during the qualitative evaluation.
• Provides substantive technical input into the development of data collection tools, including survey and interview tools, and methodology for covering target states
• Support the data collection process, including conducting several KIIs and FGDs with stakeholders including women, health care providers, etc
• Support in the presentation of preliminary findings on data collected from stakeholders' engagement and desk review
• Coordinates closely with other evaluation team members to ensure quality evaluation
• Support the team lead in writing the draft evaluation report with support from the team members, taking into consideration feedback from the Out-brief presentation.
• Respond to USAID comments on the draft report, incorporate USAID/Nigeria staff comments into the final version of the report, and finalize the report.
• Present the evaluation results to diverse audiences according to USAID standard reporting
• Work collaboratively with team members throughout design, implementation, analysis, and report writing to complement each other's areas of expertise.

Qualifications

The candidate is expected to have the following qualifications:

• Education: A Bachelor's Degree in Accounting, Business Administration, Economics, or a related field is preferable. A chartered accountant who has worked in public service or evaluated a drug revolving fund activity and has proven experience with economic analysis, public finance, and investments will be advantageous.

Working experience:

• Minimum of seven years of progressive working experience in accounting and financial management systems in the public sector /healthcare domain.
• Experience in maintaining and keeping proper books of accounting recounting records
• Ability to review the DRF financial management system
• Experience in preparation and review of monthly bank reconciliation and financial statements
• Ability to review DRF fund valuation statements
• Conduct and evaluate independent review of vouchers, internal control systems, and financial reporting documents
• Review contract documents, vouchers, and payment records.
• Experience with commodities pricing policy and application of DRF mark-up elements.
• Review funding gap assessments
• Carry out a detailed DRF financial risk assessment
• The consultant should adhere to ethical guidelines, obtain informed consent, and protect the confidentiality and anonymity of participants.

go to method of application »

Department: Program
Employment Type: Independent Contractor / Short-Term Technical Assistance (STTA)
Team: USAID/Nigeria MEL Support Activity
Reporting to: Assessment and Evaluation Advisor
Period of Performance: November 2024 – May 2025
Project: USAID/Nigeria Health Population and Nutrition (HPN) Office

Background

• Navanti supports a Monitoring, Evaluation, and Learning (MEL) Support Activity program that assists USAID/Nigeria in advancing its broader organizational learning and development efforts.
• This program strengthens the Mission’s capacity and performance in programmatic monitoring, evaluation, learning, collaborating, and adapting.
• The MEL Support Activity closely aligns with USAID/Nigeria’s Country Development Cooperation Strategy (CDCS).
• It provides a broad range of specialized technical assistance, training, data gathering and analysis, field-based monitoring, evaluations and assessments, facilitation of organizational learning and adaptation initiatives, and short-term technical assistance.

Overview and Evaluation Purpose

• USAID/Nigeria has engaged the MEL Support Activity to evaluate the Drug Revolving Fund (DRF) Activity to determine whether it meets its stated objectives.
• The evaluation will ascertain if the assistance provided by USAID/Nigeria through the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project on DRF Activity achieved the stated development objectives (DO).
• The evaluation also seeks to understand the lessons from this Activity in Nigeria.
• The purpose is to evaluate the effectiveness, promote accountability, inform decision-making, ensure the program's sustainability and impact on improving access to essential medicines and healthcare services, and inform USAID/Nigeria’s potential future support for drug revolving funds.
• The study will provide specific insights into the following proposed states:
  • North-West: Zamfara, Sokoto
  • North-East: Bauchi
  • North-Central: Nasarawa

About Drug Revolving Fund (DRF)

• The drug revolving fund (DRF) is a financing mechanism used in healthcare to improve access to essential drugs and medicines.
• The primary goal of a DRF is to ensure a steady supply of quality medications and to prevent stockouts or shortages in public health facilities, such as hospitals and health centers.

The purpose of the DRF is as follows:

• Ensure the availability and sustainability of quality health commodities.
• Ensure accessibility and affordability of health commodities.
• Contribute to the attainment of universal health coverage.
• Support health care for the vulnerable.

USAID expected the DRF support to achieve the following high-level results:

• Improved access to essential medicines particularly in underserved areas at an affordable rate
• Strengthened health systems through improved capacity, governance, and coordination of supply chain management, procurement processes, and monitoring systems.
• Curtail dependence on external funding.
• Streamline the procurement and distribution of medicines, leading to more efficient health service delivery. This can result in shorter waiting times, improved patient satisfaction, and improved overall quality of care in health facilities.
• Improve revenue generation and sustainability through revolving/recycling funds from the sale of medicines and pharmaceutical products.
• The primary users of the evaluation findings will be the USAID Health Population and Nutrition (HPN) Office, other U.S. Government (USG) officials, non-USG donor organizations, GON, and private sector firms, all of whom can use the findings to improve and build knowledge.
• The result of this evaluation will be used by the Mission, GON, implementing partners, and other stakeholders to enhance accountability and learning and to inform decisions on further investment and whether or not the DRF is being re-capitalized.
• The estimated start date will be November 11, 2024. The evaluation is expected to last until May 2025.

Position Description

• Navanti is seeking a Supply Chain Specialist to support the team lead in developing context-specific tools for engaging various stakeholders, providing context to the evaluation, and supporting the development of the report.
• The Logistics & Supply Chain Management Expert will work with the team leader to conduct interviews, analyze the data, and develop the evaluation report responsible for the overall coordination and management of the evaluation team’s effort and for ensuring a rigorous and high-quality evaluation in the locations stated above.
• Under the guidance of the MEL Support Activity, the Supply Chain Specialist is expected to work closely with the USAID/Nigeria-HPN team.
• The team will use a combination of literature review, secondary analysis of population-based surveys, and quantitative/qualitative data collection through focus group discussions and in-depth interviews to gather insights to answer the study questions, with a special focus on data from the four states listed above.
• The team is also expected to propose based evaluation methodology/approach as required.

Responsibilities

• The health financing specialist will be responsible for reviewing relevant documents, and approaches to the DRF Activity, providing context on warehouse management, and supply procedures, maintenance, and rectification of technical glitches.
• S/he will support in identifying key stakeholders developing data collection tools based on the objective of the evaluation, and providing general context.
• S/he will be responsible for providing direct technical assistance to the team leader on key strategies to engage targeted stakeholders in conducting the evaluation. The expert will:
  • Participate in the evaluation kick-off session with USAID/Nigeria.
  • Support in conducting an initial desk study: gather relevant secondary materials to identify key actors and stakeholders. A summary of these findings will help to better understand the context, identify key stakeholders to be interviewed, and guide the finalization of the design for the evaluation including the questions to be explored further during the qualitative evaluation.
  • Provides substantive technical input into the development of data collection tools, including survey and interview tools, and methodology for covering target states
  • Support the data collection process, including conducting several KIIs and FGDs with stakeholders including women, health care providers, etc
  • Support in the presentation of preliminary findings on data collected from stakeholders' engagement and desk review
  • Coordinates closely with other evaluation team members to ensure quality evaluation
  • Support the team lead in writing the draft evaluation report with support from the team members, taking into consideration feedback from the Out-brief presentation.
  • Respond to USAID comments on the draft report, incorporate USAID/Nigeria staff comments into the final version of the report, and finalize the report.
  • Present the evaluation results to diverse audiences according to USAID standard reporting
  • Work collaboratively with team members throughout design, implementation, analysis, and report writing to complement each other's areas of expertise.

Qualifications

The candidate is expected to have the following qualifications:

• Candidates should possess minimum of a Master's Degree in Public Health, Public Health Supply Chain and Logistics, Pharmacy, Business Administration, or a related field
• Seven (7) years or more substantive professional experience working in pharmaceutical supply chain, commodities, logistics management, and implementing a drug revolving fund scheme in a government health facility.
• Experience evaluating and managing drug-revolving funds.
• Ability to readily analyze, understand, and discuss issues around supply chain management in the DRF mechanism. Strong quantitative and data analysis skills, and a high degree of computer literacy for data analysis, report writing, and presentation.
• Proficiency in evaluation methods, quantitative and qualitative research methods including, data collection, statistical analysis, and interpretation of findings.
• Supply chain and drug revolving fund scheme experience working with the Government of Nigeria at the national, state, and facility levels.
• Experienced supply chain management of drug revolving fund for malaria and MNCH commodities
• High level of experience in supply chain and technical expertise and knowledge of malaria and MNCH logistics management.
• The consultant should adhere to ethical guidelines, obtain informed consent, and protect the confidentiality and anonymity of participants.